PAPER Vázquez-Higuera JL, Mateo I, Sánchez-Juan P, Rodríguez-Rodríguez E, Pozueta A, Calero M, Dobato JL, Frank-García A, Valdivieso F, Berciano J, Bullido MJ, Combarros O
SEARCH RESULTS
329930 RESULTS
PAPER Kyrkanides S, Tallents RH, Miller JN, Olschowka ME, Johnson R, Yang M, Olschowka JA, Brouxhon SM, O'Banion MK
Osteoarthritis accelerates and exacerbates Alzheimer's disease pathology in mice.
J Neuroinflammation. 2011;8:112. PubMed: 21899735PAPER Alexandru A, Jagla W, Graubner S, Becker A, Bäuscher C, Kohlmann S, Sedlmeier R, Raber KA, Cynis H, Rönicke R, Reymann KG, Petrasch-Parwez E, Hartlage-Rübsamen M, Waniek A, Rossner S, Schilling S, Osmand AP, Demuth HU, von Hörsten S
Selective hippocampal neurodegeneration in transgenic mice expressing small amounts of truncated Aβ is induced by pyroglutamate-Aβ formation.
J Neurosci. 2011 Sep 7;31(36):12790-801. PubMed: 21900558PAPER Devi L, Ohno M
7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease.
Neuropsychopharmacology. 2012 Jan;37(2):434-44. Epub 2011 Sep 7 PubMed: 21900882PAPER Selkoe DJ
Resolving controversies on the path to Alzheimer's therapeutics.
Nat Med. 2011 Sep;17(9):1060-5. PubMed: 21900936PAPER Johnson RD, Schauerte JA, Wisser KC, Gafni A, Steel DG
Direct observation of single amyloid-β(1-40) oligomers on live cells: binding and growth at physiological concentrations.
PLoS One. 2011;6(8):e23970. PubMed: 21901146PAPER Swaminathan S, Shen L, Risacher SL, Yoder KK, West JD, Kim S, Nho K, Foroud T, Inlow M, Potkin SG, Huentelman MJ, Craig DW, Jagust WJ, Koeppe RA, Mathis CA, Jack CR, Weiner MW, Saykin AJ,
Amyloid pathway-based candidate gene analysis of [(11)C]PiB-PET in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort.
Brain Imaging Behav. 2011 Sep 8; PubMed: 21901424PAPER Cai Z, Zhao B, Ratka A
Oxidative stress and β-amyloid protein in Alzheimer's disease.
Neuromolecular Med. 2011 Dec;13(4):223-50. PubMed: 21901428PAPER Chiu AY, Rao MS
Cell-based therapy for neural disorders--anticipating challenges.
Neurotherapeutics. 2011 Oct;8(4):744-52. PubMed: 21901585PAPER Yagi T, Ito D, Okada Y, Akamatsu W, Nihei Y, Yoshizaki T, Yamanaka S, Okano H, Suzuki N
Modeling familial Alzheimer's disease with induced pluripotent stem cells.
Hum Mol Genet. 2011 Dec 1;20(23):4530-9. PubMed: 21900357PAPER Huang RY, Garai K, Frieden C, Gross ML
Hydrogen/deuterium exchange and electron-transfer dissociation mass spectrometry determine the interface and dynamics of apolipoprotein E oligomerization.
Biochemistry. 2011 Nov 1;50(43):9273-82. Epub 2011 Oct 5 PubMed: 21899263PAPER Hazewinkel M, Barkhof F
Imaging Alzheimer in 2011.
Neuroradiology. 2011 Sep;53 Suppl 1:S145-7. PubMed: 21863421PAPER Iwatsubo T
[Dementia: progress in diagnosis and treatment; editorial, towards the preclinical treatment of Alzheimer disease].
Nihon Naika Gakkai Zasshi. 2011 Aug 10;100(8):2089-91. PubMed: 21899138PAPER Shimohama S
[Dementia: progress in diagnosis and treatment; Topics, I. Basic knowledge of dementia and pathophysiology; 1. The concept and pathophysiology of dementia of Alzheimer-type].
Nihon Naika Gakkai Zasshi. 2011 Aug 10;100(8):2092-8. PubMed: 21899139PAPER Kaufmann D, Dogra AK, Wink M
Myrtenal inhibits acetylcholinesterase, a known Alzheimer target.
J Pharm Pharmacol. 2011 Oct;63(10):1368-71. PubMed: 21899553Current Filters
No filters selected